BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6158976)

  • 1. Response of an in vivo-in vitro tumour to X-rays and cytotoxic drugs: effect of tumour disaggregation method on cell survival.
    Rasey JS; Nelson NJ
    Br J Cancer Suppl; 1980 Apr; 4():217-21. PubMed ID: 6158976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tumor dissaggregation on results of in vitro cell survival assay after in vivo treatment of the EMT-6 tumor: x-rays, cyclophosphamide, and bleomycin.
    Rasey JS; Nelson NJ
    In Vitro; 1980 Jul; 16(7):547-53. PubMed ID: 6157635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell survival and growth delay in rat R-1 tumours after radiation and vinblastine treatment.
    Kal HB; Barendsen GW
    Br J Cancer Suppl; 1980 Apr; 4():275-8. PubMed ID: 6932937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human colon adenocarcinoma xenograft--radiation response, cellular composition, and tumor disaggregation.
    West CM; Keng PC; Siemann DW; Sutherland RM
    J Natl Cancer Inst; 1987 Feb; 78(2):371-6. PubMed ID: 3468298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of solid tumor cells exposed to chemotherapeutic agents in vivo: cell survival after 2- and 24-hour exposure.
    Hahn GM; Ray GR; Gordon LF; Kallman RF
    J Natl Cancer Inst; 1973 Feb; 50(2):529-33. PubMed ID: 4121931
    [No Abstract]   [Full Text] [Related]  

  • 6. Sensitivity to cytotoxic agents of the EMT6 tumour in vivo: tumour volume versus in vitro plating. 1. Cyclophosphamide.
    Twentyman PR
    Br J Cancer; 1977 Feb; 35(2):208-17. PubMed ID: 836758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory cells in solid murine neoplasms. I. Tumor disaggregation and identification of constituent inflammatory cells.
    Russell SW; Doe WF; Hoskins RG; Cochrane CG
    Int J Cancer; 1976 Sep; 18(3):322-30. PubMed ID: 182647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery from sublethal damage by acutely hypoxic tumour cells in vivo and in vitro.
    McNally NJ; George KC; de Ronde J
    Br J Radiol; 1979 Aug; 52(620):642-9. PubMed ID: 486894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors. V. Bleomycin.
    Twentyman PR; Kallman RF; Brown JM
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1499-501. PubMed ID: 94050
    [No Abstract]   [Full Text] [Related]  

  • 10. An in situ method for estimating cell survival in a solid tumor.
    Alfieri AA; Hahn EW
    Cancer Res; 1978 Sep; 38(9):3006-11. PubMed ID: 679208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour response endpoints in the BA1112 rat sarcoma.
    Martin DF; Moulder JE; Fischer JJ
    Br J Cancer Suppl; 1980 Apr; 4():271-4. PubMed ID: 6932936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour response to chemotherapy in animals that have been treated with the same drugs prior to tumour implantation: a model for studying host effects on apparent drug resistance.
    Luk CK; Tannock IF
    Br J Cancer; 1988 Aug; 58(2):133-8. PubMed ID: 3166902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disaggregation studies of xenograft solid tumors grown from pure or admixed clonal subpopulations from a heterogeneous human colon adenocarcinoma.
    Leith JT; Faulkner LE; Bliven SF; Lee ES; Glicksman AS; Dexter DL
    Invasion Metastasis; 1985; 5(6):317-35. PubMed ID: 4066205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of cyclophosphamide cytotoxicity in vivo by the benzamide analogue pyrazinamide.
    Horsman MR; Chaplin DJ
    Br J Cancer; 1994 Apr; 69(4):648-54. PubMed ID: 8142253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses of cycling and noncycling cells to 1,3-bis(2-chloroethyl)-1-nitrosourea and to bleomycin.
    Hahn GM; Gordon LF; Kurkjian SD
    Cancer Res; 1974 Sep; 34(9):2373-7. PubMed ID: 4135685
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors--II. Cyclophosphamide.
    Twentyman PR; Kallman RF; Brown JM
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1425-7. PubMed ID: 536251
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of the effects of radiation on tumour growth delay and cell survival. The effect of radiation quality.
    McNally NJ
    Br J Radiol; 1975 Feb; 48(566):141-5. PubMed ID: 1125537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new method of determining the fraction of hypoxic cells in a transplantable murine sarcoma.
    Hill RP; Bush RS
    Radiat Res; 1977 Apr; 70(1):141-53. PubMed ID: 850728
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation.
    Stephens TC; Peacock JH; Steel GG
    Br J Cancer; 1977 Jul; 36(1):84-93. PubMed ID: 889685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tempol reduces the therapeutic effect of cyclophosphamide on an experimental tumour model.
    Kaledin VI; Popova NA; Nikolin VP; Vasilieva ED; Kirilyuk IA; Grigor'ev IA
    Free Radic Res; 2009 Jul; 43(7):685-90. PubMed ID: 19526393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.